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Background. Metabolic risk factors like insulin resistance and dyslipidemia are frequently observed in severly obese children. We
investigated the hypothesis that moderate weight reduction by a low-threshold intervention is already able to reduce insulin
resistanceandcardiovascularriskfactorsinseverelyobesechildren.Methods.Agroupof58severelyobesechildrenandadolescents
between8and17yearsparticipatinginasix-month-longoutpatientprogramwasstudiedbeforeandaftertreatment.Theprogram
includedbehavioraltreatment,dietaryeducationandspeciﬁcphysicaltraining.Metabolicparametersweremeasuredinthefasting
state, insulin resistance was evaluated in an oral glucose tolerance test. Results. Mean standard deviation score of the body mass
index (SDS-BMI) in the study group dropped signiﬁcantly from +2.5 ± 0.5 to 2.3 ± 0.6 (P<0.0001) after participation in the
program. A signiﬁcant decrease was observed in HOMA (6.3 ± 4.2 versus 4.9 ± 2.4, P<0.03, and in peak insulin levels (232.7 ±
132.4 versus 179.2 ± 73.3μU/mL, P<0.006). Signiﬁcant reductions were also observed in mean levels of hemoglobin A1c,t o t a l
cholesterol and LDL cholesterol. Conclusions. These data demonstrate that already moderate weight reduction is able to decrease
insulin resistance and dyslipidemia in severely obese children and adolescents.
1.Introduction
During the last decade a steady rise in the prevalence
of obesity in children and adolescents has been observed
worldwide [1, 2] and in several age-groups the extent of
obesity was also on the increase. Concurrently certain dis-
eases, characteristically occurring in middle-age adults in
association with enhanced body fat mass (e.g., metabolic
syndrome and type 2 diabetes), have emerged in children
and adolescents with severe obesity, suggesting a coherence
between both trends [3, 4]. Likewise, further investigations
have shown that obese children and adolescents have a high
risk between 30 and 80% for the persistence of overweight
into adulthood, and that morbidity and mortality are
higher in those obese adults who became overweight during
childhood compared to those whose weight-gain evolved
later in life [5]. On the other hand epidemiological studies
showed that the majority of severely obese adults became
overweight when they were still children. A tremendous
increase in obesity-related morbidity and furthermore an
immense rise in the medical costs associated with it, are
to be expected, if this trend continues [6]. For instance, at
present type 2 diabetes mellitus is already predominant in
some pediatric diabetes centers in the USA due to severe
obesity [7]. In Germany more and more obese adolescents
are also aﬀected by type 2 diabetes mellitus [8].
Insulin resistance is a common feature of obesity in the
young and precedes impaired glucose tolerance and type 22 International Journal of Endocrinology
diabetes mellitus. In studies performed at our center, insulin
resistance was observed in approximately 70% of severely
obese children and adolescents. These data are in accordance
with similar studies performed in other European countries
and in the United States [9, 10]. It is imperative that
we address the obesity epidemic in young people by the
development of speciﬁc programs; failure to do so could
have severe consequences for the economy. The parents of
obese children are usually also markedly obese. This feature
may to a certain degree be due to the transmission of
adverse parental genes, but more often it can be attributed
to the lifestyle transferred from parents on their children
[11]. It is evident that the most promising way to avoid
further morbidity is the treatment of the problem in the
whole family [12]. Meanwhile a variety of studies have
demonstratedthatmultimodallifestyleinterventionsinclud-
ing behavioral measures, exercise programs, and dietary
advicing are eﬀective in the treatment of obese children
[1,13].Notsurprisingly,moreintensiveprogramsweremore
eﬀective in reducing overweight in children. However, many
obese children are not able to participate in such intensive
programs. Low-threshold obesity intervention programs
facilitate participation for families, since the children can
continue their daily life routines. Reinehr and Andler have
shown in their study that a reduction of SDS-BMI of at least
0.5isrequiredforanimprovementofatherogenicproﬁleand
insulinresistance[14].Thereforetheaimofthepresentstudy
was to investigate whether a low-threshold obesity program
which achieves moderate weight reduction is able to alter
cardiovascular risk factors in severe obese adolescents.
2.MaterialsandMethods
2.1. Patients. The study population consisted of 32 girls
and 26 boys between the ages of 8 and 17 with a mean
age of 12.6 ± 2.2 years with profound obesity (body mass
index >97th percentile for ages according to standards for
German children [15]). Body weight was measured in the
morning in a fasting state using a digital scale to the
nearest 0.1kg. Height was measured using a wall-mounted
stadiometer. Body mass index (BMI) was calculated (weight
in kilograms divided by the body height in square meters),
and the standard deviation score of the BMI (SDS-BMI) was
calculated according to Cole [16]. Informed consent of the
patients and their parents was given before the study began.
2.2. Oral Glucose-Tolerance Test. Participants were studied at
8.00 to 8.30a.m. after a 12-hour overnight fasting period.
An antecubital intravenous catheter was inserted for blood
sampling and maintained open by infusion of physiological
saline solution. All participants rested during the test.
Baseline blood-samples were obtained, and thereafter the
participants received orally a standardized glucose solution
(Dextro-OGT, Roche, Basel, Switzerland) in a dose of 1.75g
perkilogramofbodyweightuptoamaximumof75g.Blood
samples were collected at 30 to 120 minute intervals.
2.3. Biochemical Assays. Blood samples for measurements of
glucose were collected in sodium ﬂuoride containing tubes,
and glucose was measured by the glucose-oxidase method.
Insulin and leptin were measured by radio-immunoassay.
Total cholesterol, HDL cholesterol, LDL cholesterol, and he-
moglobin A1c (HbA1c) were measured from fasting blood
samplings.Allbiochemicalmeasurementswereperformedin
an accredited hospital laboratory.
2.4.InterventionProgram. Medicalexaminationandpsycho-
logical evaluation were performed before entry into the pro-
gram. Children with severe medical disorders besides obesity
or with severe psychosocial impairments were excluded. Our
six-month program consists of
(a) nutritional consultation with the family members (6
monthly sessions),
(b) cognitive-behavioral training in groups of 8–10 par-
ticipants (6 monthly sessions),
(c) physical activity programs in groups of 8–10 partici-
pants (24 weekly lessons).
All procedures were carried out by a nutritionist, a
psychologist, and physiotherapists in our institution. During
the program, the participants maintained their normal
daily routine, and visited school as usual. Children and
adolescents participated once a week in a speciﬁc physical
training program for obese adolescents. The exercise lessons
consisted of one-hour “indoor cycling” in groups of 8 to
10 children on speciﬁc stationary bikes under instruction.
In addition, children and their families were encouraged to
increase their physical activities in daily life, for example,
by watching fewer TV programs or driving less or by doing
moreactiveleisuretimeactivities.Inthenutritioncounseling
sessions the participants and their parents were guided by
the nutritionist to change their eating habits to a low fat
and healthy diet according to the national recommendations
of the Research Institute of Child Nutrition Dortmund
(http://www.fke-do.de) and the German Nutrition Society
(http://www.dge.de/). Particularly the amount of mono-
and disaccharides in sweets or sweetened drinks needed
to be limited in many subjects. Other dietetic problems
like generally too large amounts, poor diets without “ﬁve
a day” or not enough diaries or drinking amounts are
some other items of the nutrition sessions [17]. The change
of family eating patterns was recommended and trained
in terms of ﬂexible control [18]. The cognitive-behavioral
training was performed according to a program developed
by Warschburger et al. [19].
2.5. Statistical Analysis and Calculations. The homeostasis
model assessment (HOMA) was used as one measure of
insulin resistance and was calculated as fasting glucose
(mmol/L) × fasting insulin (μU/mL)/22.5) [20]. Nonpara-
metric procedures were used for all comparisons. Mann-
Whitney test was used for comparison of sex- and age-
speciﬁc diﬀerences. Wilcoxon signed rank test was used for
comparison before and after treatment. The StatView-
statistical analysis program (SAS-Europe, Heidelberg) wasInternational Journal of Endocrinology 3
Table 1: Anthropometric data of the study group before and after participation in the obesity intervention program.
Before treatment After treatment P
Min Mean Max Min Mean Max
Height (cm) 125 163.1 187.8 131.4 164.8 188.5 <0.0001
Weight (kg) 35.3 84.5 143.5 37.4 83.3 146.3 n.s.
BMI 22.7 30.7 44.3 21.7 29.5 44.5 <0.0001
SDS-BMI +1.9 +2.5 +3.8 +1.3 +2.3 +3.7 <0.0001
used for statistical analysis. A probability value of <0.05 was
considered signiﬁcant.
3. Results
Medical examination was performed before and at the end of
the program. Mean BMI of the study group was 30.7kg/m2±
5.0 before treatment and 29.5kg/m2± 4.7 after treatment
(Table 1). For statistical analysis SDS-BMI was used, since
BMI normal values are age-dependent during childhood
and adolescence. Mean SDS-BMI of the study group before
treatmentwas+2.5±0.5. There were no statistical signiﬁcant
diﬀerencesinSDS-BMI,orinlaboratoryvaluesbetweengirls
and boys (data not shown), and therefore boys and girls were
not analyzed separately. SDS-BMI dropped signiﬁcantly to
2.3 ± 0.6 after weight reduction (P<0.0001) as shown
in Table 1. Fasting glucose levels were within the normal
range in all participants, and none of the participants had
impaired glucose tolerance, deﬁned by 2-hour glucose levels
>7.7mmol/L.However,therewasamarkedinsulinresistance
determined by fasting insulin levels, peak insulin levels,
and homeostasis model assessment (HOMA). Mean HOMA
was 6.3 ± 4.2 before treatment and dropped signiﬁcantly
to 4.9 ± 2.4 after treatment (Table 2). Mean fasting insulin
was 28.3 ± 16.5μU/mL before treatment and decreased
signiﬁcantly to 23.8 ± 10.6μU/mL after treatment as shown
in Table 2. Peak insulin levels were elevated and also
decreased signiﬁcantly after participation in the program as
shown in Table 2. Furthermore, the area under the curve
for insulin in the oGTT (AUCins) was also signiﬁcantly
reduced after weight reduction (data not shown). We noted
a good correlation between HOMA and peak insulin levels
(r = 0.81, P<0.0001). Fasting glucose levels showed no
signiﬁcant diﬀerences before and after treatment (4.7 ± 0.6
versus 4.7 ± 0.5mmol/L, whereas peak glucose levels in the
oGTT were seen at 60 minutes and were signiﬁcantly higher
before weight loss (6.9 ± 1.4 mmol/L versus 6.3 ± mmol/L,
P<0.03; Table 2). The mean HbA1c-level was 5.6 ± 0.4%
before treatment and decreased signiﬁcantly to 5.4 ± 0.3
(P<0.0004) as shown in Figure 1. A signiﬁcant decrease
was also noted in leptin levels (Figure 2). We noted a highly
signiﬁcant correlation between leptin levels and HOMA (r =
0.433, P>0.0001) as well as between leptin levels and
peak insulin levels (r = 0.61, P<0.006) before treatment.
HOMA levels above 4, considered to represent a high risk
for the development of metabolic syndrome, were observed
in 66% before and in 54% after weight reduction (Table 3).
None of the participants had impaired glucose tolerance
Table 2: Metabolic characteristics before and after participation in
the obesity intervention program. Data are shown as means ± SD.
Before
treatment
After
treatment P
Fasting insulin (μU/mL) 28.3 ±16.52 3 .8 ±10.6 <0.03
Peak insulin (μU/mL) 232.7±132.4 179.2 ±73.3 <0.006
HOMA 6.3 ±4.24 .9 ±2.4 <0.03
Fasting glucose (mmol/L) 4.7 ±0.64 .7 ±0.5n . s .
Peak glucose (mmol/L) 6.9 ±1.46 .3 ±1.4 <0.03
Total cholesterol (mmol/L) 4.5 ±0.94 .1 ±0.9 <0.0001
HDL cholesterol (mmol/L) 1.1 ±0.20 .9 ±0.2 <0.002
LDL cholesterol (mmol/L) 2.9 ±0.82 .5 ±0.7 <0.004
Triglycerides (mmol/L) 1.3 ±0.61 .2 ±0.5n . s .
P<0.0004
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Figure 1: Hemoglobin A1c before and after weight loss. Hemoglo-
bin A1c (%) was measured before and after weight loss as described
in the methods. Box plots represent the 10th, 25th, 50th, 75th, and
90th percentiles. Statistical analysis was performed by Wilcoxon
signed rank test.
of diabetes mellitus type 2, according to WHO standards.
However, we observed HbA1c values above the normal range
in 5 adolescents (8.6%) before treatment. At the end of the
treatment period all ﬁve individuals had HbA1c levels within
the normal range (Table 3).
Furthermore, lipid and lipoprotein fractions were ana-
lyzed before and after weight reduction. As shown in
Table 2, mean levels of total cholesterol and LDL cholesterol4 International Journal of Endocrinology
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Figure 2: Leptin levels before and after weight loss. Leptin (ng/mL)
was measured before and after weight loss as described in the
methods. Box plots represent the 10th, 25th, 50th, 75th, and 90th
percentiles. Statistical analysis was performed by Wilcoxon signed
rank test.
decreased signiﬁcantly after weight reduction, while no sig-
niﬁcant diﬀerence was noted in mean triglyceride levels. In
contrast to these favorable changes, HDL cholesterol levels
also decreased during the treatment period (1.1 ± 0.2v e r s u s
0.9 ± 0.2mmol/L, P<0.002). Since mean levels might not
reﬂect the risk proﬁle, we also determined the percentage
of participants with levels within pathological ranges before
andafterweightreduction.Hypercholesterolemia,deﬁnedas
total cholesterol levels >5.0mmol/L, was noted in 25% of
participants before treatment, and in 18% after treatment.
LDL levels >3.5mmol/L were observed in 16% before and
only in 10% after weight reduction. Elevated triglyceride
levels (>1.6mmol/L) were seen in about 30% before and
after weight reduction (Table 3). Decreased HDL levels
(<0.9mmol/L) were seen in 27% before treatment and in-
creased up to 51% after treatment.
4. Discussion
The present study demonstrates that a low threshold obesity
intervention program is eﬀective in reducing BMI in severely
obese children and adolescents. Besides the positive impact
on obesity, we could demonstrate that risk factors for
cardiovascular diseases were also signiﬁcanty lowered after
participation in the intervention program. The program
consisted of nutritional consulting, behavioral training, and
physical activity programs. All three elements are considered
to be important for the success of an obesity program
[21]. Nutritional education was an important element of
the program, and it became evident that repeated sessions
would be necessary to change the eating habits of the
families. This observation is in accordance with a long-term
follow-up study of overweight children showing that single
consultation sessions are not suﬃcient to achieve weight
loss [22]. The nutritional consultation was performed on a
Table 3:Patientsatriskbeforeandafterparticipationintheobesity
intervention program.
Before treatment After treatment
Total cholesterol >5mmol/L 25% 18%
LDL cholesterol >3.5mmol/L 16% 10%
HDL cholesterol <0.9mmol/L 27% 51%
Triglycerides >1.6mmol/L 30% 30%
HOMA >4 66% 54%
HbA1c >6.1% 10% 0%
family basis in orderto give individual advice on the families’
eating habits. It was important that the parent mainly re-
sponsible for preparing the meals attended these sessions.
The behavioral training and physical activity programs were
performed in groups of 8–10 participants without other
family members. Although most participants were antipathy
to the cognitive-behavioral training at the beginning, the
majority gave positive feedback at the end of the program.
The important role of physical activity in weight reduction
programs has been demonstrated [23]. The physical activity
program was well accepted by most of the participants.
Impaired glucose tolerance, insulin resistance, and a
higher prevalence of risk factors for cardiovascular diseases
are common metabolic features of childhood obesity [9, 10,
24]. However, in contrast to adults, it is to date not possible
to correlate the degree of childhood obesity to the associated
health consequences, because clear-cut evidence for thresh-
old values is missing. Compared to more intensive in-patient
programs the weight reduction achieved by our program
was moderate. Nevertheless profound improvements in the
metabolic situation of the children and adolescents were
observed. Marked insulin resistance was observed in the
study group before treatment. Several models for measuring
insulin resistance have been proposed, but to date no general
agreement has been made on the preferential model [25].
The thresholds for insulin resistance in childhood and
adolescents have been adapted from those designed for
adults. We chose HOMA, fasting insulin levels, and peak
insulin levels as measures for insulin resistance, since these
parameters have been used in comparable studies performed
in children and adolescents [10, 14, 25]. Participation in the
program led to a marked reduction of insulin resistance as
shown in Table 2. Only participants who participated in the
whole program were included into the study. Long et al.
demonstratedinadultsthatmoderateweightreductionof5–
10% can prevent progression of impaired glucose tolerance
inseverelyobesesubjects[26].ReinehrandAndlerpublished
improvements in HOMA and in lipid proﬁles after partic-
ipation in a more intensive weight reduction program in
children [14]. HbA1c-levels, reﬂecting long-term blood sugar
regulation, were within the normal range in most patients,
and only slightly elevated in 5 individuals. A signiﬁcant
decrease in HbA1c was observed after weight reduction,
despite the fact that a carbohydrate-enriched diet was
recommended during the program. The reduction in mean
HbA1c might be an indicator of improved carbohydrateInternational Journal of Endocrinology 5
metabolism and a consequence of the reduction of insulin
resistance. Such an eﬀect of weight reduction on HbA1c has
not been reported before. According to recent data, even an
increasing HbA1c-level above 5% is already associated with
elevated cardiovascular risk in adults. Therefore, the changes
inHbA1c weobservedinourstudycouldbequitemeaningful
in the long term [27].
Plasma leptin levels are positively correlated with BMI,
and several studies demonstrated that obese subjects exhibit
leptinresistance[28].Associationsbetweeninsulinresistance
a n dl e p t i nl e v e l sh a v eb e e nr e p o r t e di nc h i l d r e n[ 29]. It was
therefore not surprising that leptin levels decreased due to
weightreductioninthepresentstudy.Arslanianetal.showed
a signiﬁcant correlation between leptin levels and fasting
insulin levels [30]; an even more pronounced correlation
could be demonstrated between HOMA or peak insulin
levels on one hand and leptin levels on the other. It seems
that leptin resistance and insulin resistance in obese children
and adolescents are closely related and are possibly regulated
in the same sense.
Dyslipidemia is a frequent feature of obesity in adults
as well as in children [31–33]. Mean levels of plasma lipids
were within the normal range before treatment (see Table 2),
but dyslipidemia deﬁned by elevated total cholesterol, LDL
cholesterol, triglycerides, and reduced HDL cholesterol was
seen in almost 25% of the study group before treatment.
A signiﬁcant reduction was achieved in total cholesterol
and LDL cholesterol by weight reduction, while triglyc-
erides showed no signiﬁcant changes. These ﬁndings are
in accordance with data by Reinehr and Andler who also
demonstrated signiﬁcant changes in LDL cholesterol, and to
a lesser degree in triglycerides, while total cholesterol was
not measured in that study [14]. HDL cholesterol levels
decreased also during the intervention. This phenomenon
appears to be temporary due to the low calorie and low fat
diet and has been described in adults before [34]. Reinehr
and Andler also reported that HDL cholesterol decreased
during the period of dieting but increased again after stabi-
lization of the body weight [14]. A recent systematic review
showed improved HDL-cholesterol proﬁles after weight loss
in most studies [35]. The reduction in HDL-cholesterol in
the present study might be due to the fact that low fat diets
were recommended in our program.
Insummarywecoulddemonstratethatalreadymoderate
weight reduction has beneﬁcial consequences on multiple
factors involved in the development of the metabolic syn-
drome and thereby may help to prevent the development of
diabetes mellitus type 2 in these individuals.
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